Table 1 Patient demographics.

From: Topical nitroglycerin to detect reversible microcirculatory dysfunction in patients with circulatory shock after cardiovascular surgery: an observational study

 

Preoperative control

n = 20

Nitroglycerin challenge

n = 20

Age, years

67 ± 11

64 ± 9

Sex, male

15, 75%

15, 75%

euroSCORE II

1.6 ± 1.5

2.7 ± 2.9

Performed operation (n, %)

Coronary artery bypass grafting (CABG)

7, 35%

8, 40%

CABG + valve replacement/repair

3, 15%

5, 25%

Valvular surgery only

7, 35%

4, 20%

Aortic surgery

3, 15%

3, 15%

Comorbidities (n, %)

Hypertension

11, 55%

17, 85%

Diabetes

5, 25%

8, 40%

Heart failure with reduced ejection fraction (< 30%)

0, 0%

3, 15%

Chronic kidney disease

0, 0%

6, 30%